According to a comprehensive industry report by Intel Market Research, the global Acrylic Injection Resin market was valued at USD 2,168 million in 2024 and is projected to grow to USD 2,927 million by 2031, expanding at a steady CAGR of 4.4% during the forecast period (2024-2031). This growth reflects the material's expanding applications across multiple industries and the increasing demand for durable, transparent, and chemically resistant polymer solutions.
Read MoreAccording to a new report from Intel Market Research, the global Cell Sorting Magnetic Beads market was valued at USD 457 million in 2024 and is projected to reach USD 1,160 million by 2031, growing at an impressive CAGR of 14.4% during the forecast period (2024-2031). This accelerated growth is fueled by expanding applications in immunotherapy research, rising demand for targeted cell isolation techniques, and technological advancements in magnetic separation systems.
Read MoreAccording to a new report from Intel Market Research, the global Postpartum Care and Rehabilitation market was valued at USD 9,094 million in 2024 and is projected to reach USD 19,170 million by 2031, growing at a strong CAGR of 11.4% during the forecast period (2024-2031). This significant growth is driven by increasing awareness of maternal health, rising disposable incomes in developing nations, and the growing professionalization of postnatal care services worldwide.
Read MoreAccording to a new report from Intel Market Research, the global Laparoscopic Fascial Closure System market was valued at USD 301 million in 2024 and is projected to reach USD 462 million by 2031, growing at a steady CAGR of 6.3% during the forecast period (2024-2031). This growth is driven by the rising adoption of minimally invasive surgical techniques, increasing prevalence of hernia cases, and technological advancements in closure devices.
Read MoreAccording to a new report from Intel Market Research, the global Beta Blockers market was valued at USD 9,993 million in 2024 and is projected to reach USD 12,430 million by 2031, growing at a steady CAGR of 3.1% during the forecast period (2025–2031). This growth reflects the increasing global burden of cardiovascular diseases and the expanding applications of beta-blockers in managing various health conditions.
Read More